Merck exec says company is discussing use of COVID antiviral drug in Ebola response

Merck exec says company is discussing use of COVID antiviral drug in Ebola response  Reuters

Summary aggregated from Reuters's public RSS feed. The full reporting belongs to Reuters — please read it on their site.